Search Results - "Confavreux, C"

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process by Confavreux, Christian, Vukusic, Sandra, Adeleine, Patrice

“…Prognosis of multiple sclerosis is highly variable. Clinical variables have been identified that are assessable early in the disease and are predictors of the…”
Get full text

Klinefelter Bone Microarchitecture Evolution with Testosterone Replacement Therapy by Piot, A., Plotton, I., Boutroy, S., Bacchetta, J., Ailloud, S., Lejeune, H., Chapurlat, R. D., Szulc, P., Confavreux, C. B.

“…Klinefelter Syndrome (KS) patients, defined by a 47 XXY karyotype, have increased risk of fragility fractures. We have assessed bone microarchitecture by high…”
Get full text

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors by Marcucci, G., Beltrami, G., Tamburini, A., Body, J.J., Confavreux, C.B., Hadji, P., Holzer, G., Kendler, D., Napoli, N., Pierroz, D.D., Rizzoli, R., Brandi, M.L.

“…In the past decades, new cancer treatment approaches for children and adolescents have led to a decrease in recurrence rates and an increase in long-term…”
Get full text

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy by ANDRODIAS, G, MAILLET, D, MARIGNIER, R, PINEDE, L, CONFAVREUX, C, BROUSSOLLE, C, VUKUSIC, S, SEVE, P

“…To describe effectiveness, steroid-sparing effect, and tolerance of the antiproliferative immunosuppressant mycophenolate mofetil (MMF) in neurosarcoidosis. We…”
Get full text

Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis by Confavreux, C. B., Chapurlat, R. D.

“…Inflammatory joint diseases are responsible of chronic systemic inflammation, joint degradations, deformities, and altered quality of life. Patients suffering…”
Get full text

Modafinil for fatigue in MS : A randomized placebo-controlled double-blind study by STANKOFF, B, WAUBANT, E, CONFAVREUX, C, EDAN, G, DEBOUVERIE, M, RUMBACH, L, MOREAU, T, PELLETIER, J, LUBETZKI, C, CLANET, M

“…To assess whether modafinil, a wakefulness-promoting agent, is useful for fatigue in patients with multiple sclerosis (MS). Patients with MS with stable…”
Get full text

Variabilities in µQCT-based FEA of a tumoral bone mice model by Gardegaront, M., Allard, V., Confavreux, C., Bermond, F., Mitton, D., Follet, H.

“…A finite element analysis based on Micro-Quantitative Computed Tomography (µQCT) is a method with high potential to improve fracture risk prediction. However,…”
Get full text

Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? by Pelletier, S., Confavreux, C. B., Haesebaert, J., Guebre-Egziabher, F., Bacchetta, J., Carlier, M.-C., Chardon, L., Laville, M., Chapurlat, R., London, G. M., Lafage-Proust, M.-H., Fouque, D.

“…Summary We found for the first time that in maintenance hemodialysis patients, higher sclerostin serum level was associated with severe abdominal aortic…”
Get full text

Defining the natural history of MS: the need for complete data and rigorous definitions by Confavreux, C.

Get full text

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset by Collongues, N, Marignier, R, Jacob, A, Leite, MI, Siva, A, Paul, F, Zephir, H, Akman-Demir, G, Elsone, L, Jarius, S, Papeix, C, Mutch, K, Saip, S, Wildemann, B, Kitley, J, Karabudak, R, Aktas, O, Kuscu, D, Altintas, A, Palace, J, Confavreux, C, De Seze, J

“…Background: Few data are available for patients with a late onset (≥ 50 years) of neuromyelitis optica (LONMO) or neuromyelitis optica spectrum disease…”
Get full text

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse by Vukusic, Sandra, Hutchinson, Michael, Hours, Martine, Moreau, Thibault, Cortinovis‐Tourniaire, Patricia, Adeleine, Patrice, Confavreux, Christian

“…The influence of pregnancy in multiple sclerosis has been a matter of controversy for a long time. The Pregnancy in Multiple Sclerosis (PRIMS) study was the…”
Get full text

Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques by DURAND-DUBIEF, F, BELAROUSSI, B, ARMSPACH, J. P, DUFOUR, M, ROGGERONE, S, VUKUSIC, S, HANNOUN, S, SAPPEY-MARINIER, D, CONFAVREUX, C, COTTON, F

“…Brain volume loss is currently a MR imaging marker of neurodegeneration in MS. Available quantification algorithms perform either direct (segmentation-based…”
Get full text

Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up by Belhassen, M., Confavreux, C. B., Cortet, B., Lamezec, L., Ginoux, M., Van Ganse, E.

“…Summary Limited information is available on anti-osteoporotic treatment initiation patterns in France. In 2006–2013, the most frequently prescribed first-line…”
Get full text

Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates by Confavreux, C.B, Fontana, A, Guastalla, J.P, Munoz, F, Brun, J, Delmas, P.D

“…Abstract Aromatase inhibitors have demonstrated their superiority to tamoxifen as adjuvant therapy for early breast cancer in postmenopausal women, but are…”
Get full text

Multi-frequency shear modulus measurements discriminate tumorous from healthy tissues by Nicolle, S., Palierne, J.-F., Mitton, D., Follet, H., Confavreux, C.B.

“…As far as their mechanical properties are concerned, cancerous lesions can be confused with healthy surrounding tissues in elastography protocols if only the…”
Get full text

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses by O'CONNOR, P. W, LI, D, FREEDMAN, M. S, BAR-OR, A, RICE, G. P. A, CONFAVREUX, C, PATY, D. W, STEWART, J. A, SCHEYER, R

“…Teriflunomide, a dihydro-orotate dehydrogenase inhibitor, has immunomodulatory effects, including the ability to suppress experimental allergic…”
Get full text

Neuromyelitis optica in France: A multicenter study of 125 patients by COLLONGUES, N, MARIGNIER, R, FONTAINE, B, BRASSAT, D, CLANET, M, MILH, M, PELLETIER, J, AUDOIN, B, RUET, A, LEBRUN-FRENAY, C, THOUVENOT, E, CAMU, W, ZEPHIR, H, DEBOUVERIE, M, CREANGE, A, MOREAU, T, LABAUGE, P, CASTELNOVO, G, EDAN, G, LE PAGE, E, DEFER, G, BARROSO, B, HEINZLEF, O, PAPEIX, C, GOUT, O, RODRIGUEZ, D, WIERTLEWSKI, S, LAPLAUD, D, BORGEL, F, TOURNIAIRE, P, GRIMAUD, J, BROCHET, B, VERMERSCH, P, CONFAVREUX, C, BLANC, F, DE SEZE, J, RITLENG, C, TCHIKVILADZE, M, OUTTERYCK, O, VUKUSIC, S, FLEURY, M

“…There have been few epidemiologic studies on neuromyelitis optica (NMO) and none used the recent 2006 diagnostic criteria. Here we describe the clinical,…”
Get full text

Association of UV radiation with multiple sclerosis prevalence and sex ratio in France by ORTON, S.-M, WALD, L, CONFAVREUX, C, VUKUSIC, S, KROHN, J. P, RAMAGOPALAN, S. V, HERRERA, B. M, SADOVNICK, A. D, EBERS, G. C

“…French farmers and their families constitute an informative population to study multiple sclerosis (MS) prevalence and related epidemiology. We carried out an…”
Get full text

Diffusion Tensor―MRI Evidence for Extra-Axonal Neuronal Degeneration in Caudate and Thalamic Nuclei of Patients with Multiple Sclerosis by HANNOUN, S, DURAND-DUBIEF, F, CONFAVREUX, C, IBARROLA, D, STREICHENBERGER, N, COTTON, F, GUTTMANN, C. R. G, SAPPEY-MARINIER, D

“…MS is an inflammatory demyelinating disease affecting both WM and GM. While WM lesions are easily visualized by conventional MR imaging, the detection of GM…”
Get full text

Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men? by Confavreux, C. B., Casey, R., Varennes, A., Goudable, J., Chapurlat, R. D., Szulc, P.

“…Summary The reported association between sclerostin and diabetes mellitus or abdominal fat may be biased by body size and bone mass. In older men, the…”
Get full text